Anticonvulsant and toxicity evaluation of newly synthesized 1-[2-(3,4-disubstituted phenyl) -3-chloro-4-oxoazetidin-1-yl] -3-(6-substituted -1,3-benzothiazol-2-yl)ureas

Acta Chimica Slovenica

Volumn 56, Issue 2, 2009, Pages 462-469

  Siddiqui, Nadeem ^a   Rana, Arpana ^a   Khan, Suroor A ^a   Haque, Syed Ehtaishamul ^a   Alam, M Shamsher ^a   Ahsan, Waquar ^a   Arshad, M Faiz ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Anticonvulsant activity; Azetidine; Benzothiazole; Hepato Toxicity; Maximal electroshock seizure test; Neurotoxicity

Indexed keywords

EID: 67649861424     PISSN: 13180207     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. I. Chulak, V. Sutorius, V. Sekerka, Chem. Pap. 1990, 44, 131-138.
2. M. Lacova, J. Chavancova, O. Hyblova, S. Varkonda, Chem Pap. 1991, 45, 411-118.
3. T. Papenfuhs, Ger. Offen. De. 1987, 3, 528-532.
4. U. Huseyin, K. Vanderpoorten, S. Cacciaguerra, S. Spampi- nato, J. P. Stables, P. Depovere, M. Isa, J. Med. Chem. 1998, 41, 1138-1145.
5. P. Jimonet, A. Francois, M. Barreau, J. C. Blanchard, A. Boi- rean, Ind. J. Med. Chem. 1991, 42, 2828-2843.
6. R. J. Porter, J. J. Cereghiao, G. D. Gladding, B. J. Hessie, B. White, Cleveland Clin. Quart. 1984, 51, 293-305.
7. S. N. Pandeya, S. Kohli, N. Siddiqui, Polish J. Pharmacol. 2003, 55, 565-571.
8. N. Siddiqui, S. N. Pandeya, A. P. Sen, G. S. Singh, Pharma-keftiki 1992, 4, 121-124.
9. N. Siddiqui, S. N. Pandeya, S. A. Khan, J. P. Stables, A. Rana, M. Alam, M. F. Arshad, M. A. Bhat, Bioorg. Med. Chem. Lett. 2007, 17, 255-259.
10. N. Siddiqui, A. Rana, S. A. Khan, M. A. Bhat, S. E. Haque, Bioorg. Med. Chem. Lett. 2007, 17, 4178-4182.
11. N. Siddiqui, O. Singh, M. A. Bhat, S. A. Khan, A. Rana, M. F. Arshad, J. Pharm. Res. 2006, 5, 87-91.
12. R. L. Krall, J. K. Penry, B. G. White, H. J. Kupferberg, E. A. Swinyard, Epilepsia 1978, 19, 409-128.
13. M. T. Silvina, C. M. Sung, E. B. Luis, L. E. Guillermina, Bi- oorg. Med. Chem. 2004, 12, 3857-3869.
14. P. Yogeeswari, D. Sriram, V. Saraswat, R. J. Vaigunda, K. M. Mohan, S. Murugesan, R. Thirumurugan, Eur. J. Pharm. Sci. 2003, 20, 341-346.
15. rd Ed. Mc-Graw-Hill, New York, 1968.
16. E. J. Lien, In: SAR: Side effects and drug design. New York, Marcel Dekker, Inc, 1987.
17. D. E. Leahy, QSAR: Rational approaches to the design of bi- oactive compounds. Elsevier, 1991.
18. S. Reitman, S. A. Frankel, Am. J. Clin. Pathol. 1957, 28, 56.
19. N. Tietz, Fundamentals of clinical chemistry, W. B. Eds. Saunders Company: U.S.A, 1957.
20. st Ed. Little Brown and Company: New York, 1975.
21. E. J. King, A. R. Armstrong, Can. Med. Assoc. J. 1934, 31, 376-381.
22. st Ed. Academic Press, New York, 1953.
23. st Ed. CBS Publishers and Distributors: New Delhi, 1988.